Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,058 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multicentre phase II trial of capecitabine and oxaliplatin in combination with radiotherapy for unresectable colorectal cancer: the CORGI-L Study.
Gunnlaugsson A, Anderson H, Fernebro E, Kjellén E, Byström P, Berglund K, Ekelund M, Påhlman L, Holm T, Glimelius B, Johnsson A. Gunnlaugsson A, et al. Among authors: anderson h. Eur J Cancer. 2009 Mar;45(5):807-13. doi: 10.1016/j.ejca.2008.11.017. Epub 2008 Dec 26. Eur J Cancer. 2009. PMID: 19110416 Clinical Trial.
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial.
Widmark A, Gunnlaugsson A, Beckman L, Thellenberg-Karlsson C, Hoyer M, Lagerlund M, Kindblom J, Ginman C, Johansson B, Björnlinger K, Seke M, Agrup M, Fransson P, Tavelin B, Norman D, Zackrisson B, Anderson H, Kjellén E, Franzén L, Nilsson P. Widmark A, et al. Among authors: anderson h. Lancet. 2019 Aug 3;394(10196):385-395. doi: 10.1016/S0140-6736(19)31131-6. Epub 2019 Jun 18. Lancet. 2019. PMID: 31227373 Clinical Trial.
Population-based study of treatment guided by tumor marker decline in patients with metastatic nonseminomatous germ cell tumor: a report from the Swedish-Norwegian Testicular Cancer Group.
Olofsson SE, Tandstad T, Jerkeman M, Dahl O, Ståhl O, Klepp O, Bremnes RM, Cohn-Cedermark G, Langberg CW, Laurell A, Solberg A, Stierner U, Wahlqvist R, Wijkström H, Anderson H, Cavallin-Ståhl E. Olofsson SE, et al. Among authors: anderson h. J Clin Oncol. 2011 May 20;29(15):2032-9. doi: 10.1200/JCO.2010.29.1278. Epub 2011 Apr 11. J Clin Oncol. 2011. PMID: 21482994 Clinical Trial.
Efficient reduction of loco-regional recurrences but no effect on mortality twenty years after postmastectomy radiation in premenopausal women with stage II breast cancer - a randomized trial from the South Sweden Breast Cancer Group.
Killander F, Anderson H, Rydén S, Möller T, Hafström LO, Malmström P. Killander F, et al. Among authors: anderson h. Breast. 2009 Oct;18(5):309-15. doi: 10.1016/j.breast.2009.09.006. Epub 2009 Oct 6. Breast. 2009. PMID: 19811918 Free article. Clinical Trial.
Effect of radiotherapy after breast-conserving surgery for ductal carcinoma in situ: 20 years follow-up in the randomized SweDCIS Trial.
Wärnberg F, Garmo H, Emdin S, Hedberg V, Adwall L, Sandelin K, Ringberg A, Karlsson P, Arnesson LG, Anderson H, Jirström K, Holmberg L. Wärnberg F, et al. Among authors: anderson h. J Clin Oncol. 2014 Nov 10;32(32):3613-8. doi: 10.1200/JCO.2014.56.2595. Epub 2014 Oct 13. J Clin Oncol. 2014. PMID: 25311220 Clinical Trial.
Radiation dose and relapse are predictors for development of second malignant solid tumors after cancer in childhood and adolescence: a population-based case-control study in the five Nordic countries.
Svahn-Tapper G, Garwicz S, Anderson H, Shamsaldin A, De Vathaire F, Olsen JH, Døllner H, Hertz H, Jonmundsson G, Langmark F, Lanning M, Sankila R, Tulinius H, Möller T. Svahn-Tapper G, et al. Among authors: anderson h. Acta Oncol. 2006;45(4):438-48. doi: 10.1080/02841860600658633. Acta Oncol. 2006. PMID: 16760180
3,058 results